GSK-CR219039

Study Sponsor: GSK

Study Title

A dose ranging study to assess the effect of pre-treatment with a single dose of inhaled fluticasone propionate (2 mg, 0.5 mg) on lung inflammation following challenge with inhaled ozone and intermittent exercise in healthy volunteers, relative to placebo.

Medicine or Vaccine (generic name)

fluticasone propionate

Sponsor Identification Number

CR219039

Trial Registry Identification Number(#'s)

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 1

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=CR219039

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

January 2014